Nucific Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.7/10
Best for: a named, credentialed founder physician and careful trial citations
Nucific scores below our bar on medical oversight. Read the score breakdown before signing up.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Included
Coaching
Not disclosed
No insurance needed · Vetted by our editors
GLP-1 and NAD+ telehealth that names triple board-certified physician Dr. Amy Lee as its founder, offering compounded semaglutide from $117 a month and compounded tirzepatide from $139, plus microdosed versions and brand-name Ozempic and Zepbound. The treatment price includes medication, required lab work and provider consultations, with no membership fee.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Nucific
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
MEDVi
Best for: switching between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
DudeMeds
Best for: men seeking no-fee compounded or brand-name GLP-1 injections
Editorial score · methodology
Nucific at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $117/mo (starting dose)
- What's included
- Medication · Consult · Labs
- FDA status
- No FDA warning letter on record
How we scored Nucific
Each dimension is scored algorithmically from Nucific’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.9/10At $117/mo (starting dose), Nucific runs about 35% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
7.4/10Nucific offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.4/10Online intake and platform experience (consult included in the price); 5 platform features disclosed.
Trust & Safety15%
5.6/10Some details we couldn't independently confirm; no FDA warning letters on file.
Accessibility10%
5.4/10Nucific's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.2/10Nucific provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Nucific review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: low.
What we checked
- Provider's own pricing page
- $117–$139/mo across 2 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Nucific
We walked Nucific’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Homepage offers Take The Quiz, described as taking 3 minutes with a fast eligibility review
- 2Treatment cards for compounded and brand GLP-1s and for NAD+ show 'as low as' monthly prices and route to Get Started
- 3A weight-loss estimator lets you set a current weight and shows a potential loss figure
- 4Stated flow is assessment, licensed provider review with same-day approval if eligible, then shipping from a licensed pharmacy
- Walked the public funnel only: no account was created, no health information was submitted and no payment step was reached
- Treatment cards show 'as low as' monthly prices, but not the plan length or dose behind them
- Evidence handling is better than most of the field. The 20% figure is tied to SURMOUNT-1 tirzepatide 15mg with the Jastreboff NEJM 2022 citation and an explicit not a personalized medical prediction caveat
- The NAD+ decline chart carries a long About this graphic note conceding it is an illustrative model, not a measurement, and that values differ across studies and tissues
- Testimonials disclose compensation: The people featured are real GLP-1 users who were compensated for their time
- The LegitScript logo is a plain image rather than LegitScript's verifiable seal, and no seal ID is shown, so the certification couldn't be confirmed
Nucific customer support
- Phone
- (808) 518-3595
GLP-1 medications Nucific offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Nucific offers
Beyond GLP-1s, Nucific also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
Shown as the 'as low as' monthly price; includes medication, required lab work and provider consultations.
Shown as the 'as low as' monthly price; includes medication, required lab work and provider consultations.
Ready to get started?
Plans and promotions change often, so check Nucific's current pricing and active discounts before you decide.
What we like
- Founder is named and credentialed: Dr. Amy Lee, MD, triple board-certified in Internal Medicine, Obesity Medicine and Clinical Nutrition
- One price includes medication, required lab work and provider consultations, with no membership fee
- BBB Accredited with an A+ rating, and the seal links to its BBB profile
- Cites SURMOUNT-1 properly, naming the trial, the 20.9% average and the Jastreboff NEJM 2022 source
- Discloses that featured patients were compensated for their time
- Offers compounded, microdosed and brand-name Ozempic and Zepbound in one catalog
Watch-outs
- The 'as low as' prices don't say which plan length or dose they cover
- The LegitScript badge is a self-hosted image with generic alt text rather than the issued embed, so it doesn't prove certification
- No state list and no named pharmacy, only licensed U.S. pharmacies
- Before-and-after photographs are used alongside compensated testimonials
Is Nucific worth it?
Nucific built its program around one core idea: a named, credentialed founder physician and careful trial citations. It runs $117/month (starting dose); there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. It's a fairly plain, no-frills entry in the GLP-1 providers category, without a lot of extra add-ons layered on top of the medication itself.
Worth knowing before you sign up: Nucific offers a microdosing option.
How much Nucific costs
Compounded semaglutide runs $117/month (starting dose) and compounded tirzepatide runs $139/month (starting dose).
Because Nucific's headline figure is a starting dose, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Nucific with the month-to-month prices of the alternatives below instead.
Live Vital (about $130/month) is one of the closest alternatives to weigh Nucific against.
Medications: what Nucific prescribes
Nucific prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy, which is why the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who Nucific is best for, and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program without a lot of extra features to evaluate.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Nucific is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
Nucific scores below our bar on medical oversight. Read the score breakdown before signing up.
Ready to start with Nucific?
From $117/mo (starting dose). See current pricing and start your free consultation.
Nucific might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Nucific vs…
Nucific scores6.7/10
Side-by-side pricing, medications and scores. Pick a matchup.
Nucific vs Amazon One Medical
Amazon One Medical scores 8.5/10
Nucific vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Nucific review:
Sources & methodology (as of October 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Nucific's current pricing
Plans from $117/mo (starting dose). Start your free consultation to check eligibility and today's price.